2020 ReviewYear ended March 2020

Scroll to learn more

Meiji's Business

The Meiji Group provides customers of all ages ―from infants to seniors― with a wide range of products for healthy and fulfilling lives. From delicious confectionaries and wholesome dairy products to body-enhancing nutrition supplements and vital pharmaceuticals, we make people's wellness our main mission.

Meiji's Business

Key Figures

Net Sales
¥1,252.7 billion
0.1%
Operating Income Ratio
8.2 %
0.4 percentage points
Capital Expenditures
¥71.1 billion
Operating Income
¥102.7 billion
4.4%
ROE
12.4 %
0.2 percentage points
R&D Expenses
¥31.4 billion

Breakdown by Segment

Breakdown by Segment

Business Performance Analysis

Food

Net Sales
¥1,049.5 billion
0.7%
Operating Income
¥87.3 billion
3.0%

Income Analysis

Pharmaceuticals

Net Sales
¥204.3 billion
2.9%
Operating Income
¥15.9 billion
12.2%

Income Analysis

Capital Expenditures

Capital Expenditures

Food

¥60.2 billion

Pharmaceuticals

¥10.7 billion

Cash Dividends per Share / Dividend Payout Ratio

Dividend Payout Ratio / Cash Dividends per Share

Future Prospects

It is the third year of our Medium - Term Business Plan, FYE March 2019 through FYE March 2021.
Our consolidated earnings forecast is as follows:

FYE 3/2019
Results
Net sales ¥1,254.3 billion
Operating income ¥98.3 billion
Operating income ratio 7.8%
ROE 12.2%

FYE 3/2021
Targets
¥1,253.0 billion
¥110.0 billion
8.8%
12.0%

(as of May 22, 2020)